Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ovarian cancer
ovarian cancer
Tesaro sees a $5B market opportunity for its cancer drug
Bizjournals.com
Fri, 02/17/17 - 10:14 am
Tesaro
niraparib
ovarian cancer
breast cancer
Clovis Oncology Secures FDA Approval for New Ovarian Cancer Drug
TheStreet.com
Mon, 12/19/16 - 11:51 am
Clovis Oncology
FDA
PARP inhibitors
rucaparib
ovarian cancer
Rubraca
As revenue falls, a pioneer of cancer gene testing slams rivals with overblown claims
Stat
Tue, 11/29/16 - 09:58 am
ovarian cancer
BRCA
Myriad Genetics
diagnostics
Immunovaccine’s targeted ovarian cancer therapy wins orphan drug status in EU
Drug Delivery Business
Tue, 11/22/16 - 09:52 pm
Immunovaccine
ovarian cancer
Europe
DPX-Survivac
After setback, Adaptimmune revamps T cell study
BioPharma Dive
Thu, 10/13/16 - 10:53 am
Adaptimmune
t cell therapy
NY-ESO SPEAR
ovarian cancer
These 3 Little Biotechs Just Scored Big
Motley Fool
Tue, 10/11/16 - 09:33 pm
biotech
Celldex Therapeutics
melanoma
glemba
Exelixis
Cabometyx
renal cell carcinoma
Tesaro
ovarian cancer
niraparib
Tesaro Enjoys A 'Ta-Dah' Moment
Seeking Alpha
Mon, 10/10/16 - 04:20 pm
Tesaro
ovarian cancer
niraparib
3 Cancer Drugs That Could Get an FDA OK Next Year
Motley Fool
Mon, 10/10/16 - 09:02 am
FDA
rucaparib
Clovis Oncology
ovarian cancer
binimetinib
Array Biopharma
melanoma
brigatinib
Ariad Pharmaceuticals
non-small cell lung cancer
Tesaro Drug Delays Recurrence of Ovarian Cancer, New Clinical Trial Shows
TheStreet.com
Sat, 10/8/16 - 03:49 pm
Tesaro
ovarian cancer
niraparib
Clovis Falls on Fears Ovarian Cancer Drug Inferior to Competition
TheStreet.com
Fri, 10/7/16 - 04:55 pm
Clovis Oncology
ovarian cancer
rucaparib
Lynparza
AstraZeneca
Novogen Announces FDA Approves IND Application for Cantrixil in Ovarian Cancer
Yahoo/Benzinga
Mon, 09/12/16 - 09:24 am
Novogen
FDA
Cantrixil
ovarian cancer
Clovis soars on FDA decision to bypass panel for cancer candidate
Fierce Biotech
Fri, 09/9/16 - 10:24 am
Clovis Oncology
FDA
advisory panels
rucaparib
ovarian cancer
FDA warns against widely used ovarian cancer screening test
Stat
Wed, 09/7/16 - 08:04 pm
FDA
ovarian cancer
diagnostics
Abcodia
ROCA test
Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Bloomberg
Tue, 08/23/16 - 05:47 pm
Clovis Oncology
FDA
priority review
rucaparib
ovarian cancer
Pfizer, Germany's Merck begin large ovarian cancer trial
Yahoo/Reuters
Thu, 07/7/16 - 09:25 am
Pfizer
Merck KGaA
avelumab
ovarian cancer
Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian Cancer
Yahoo
Wed, 07/6/16 - 10:58 am
Merck
Pfizer
avelumab
ovarian cancer
An Overnight Double! Could These Drugmakers Be Next?
Motley Fool
Sat, 07/2/16 - 12:36 pm
Tesaro
ovarian cancer
PARP inhibitors
niraparib
AstraZeneca
Lynparza
Medivation
AbbVie
Clovis Oncology
This Biotech's Stock Just Doubled and It's Bad News for Sanofi
Fortune
Thu, 06/30/16 - 09:27 am
Tesaro
Sanofi
ovarian cancer
niraparib
Medivation
Tesaro Shares Surge 82% Because Drug Slows Ovarian Cancer
Forbes
Wed, 06/29/16 - 10:51 am
Tesaro
ovarian cancer
niraparib
clinical trials
Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302
Yahoo
Sat, 06/11/16 - 09:59 am
Galeana Biopharma
orphan drugs
ovarian cancer
GALE-301
GALE-301/GALE-302
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »